Biontech se - adr BNTX.US 總覽分析
)BNTX 投資分析
看多重點：
- 價值≥4
- 股利≥2
分析結論
價值面評分較低，若以價值投資為目標，已經有長期投資部位可能需陸續減碼
BNTX 近期報酬表現
-2.12%
Biontech se - adr
0.38%
同產業平均
-0.07%
S&P500
與 BNTX 同產業的標的表現
- TIL Instil bio inc價值 2 分趨勢 2 分波段 2 分籌碼 2 分股利 1 分查看更多
BNTX 公司資訊
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.